Celera Proteomics Facility On-Line With Goal Of 1 Mil. Sequences Daily
This article was originally published in The Gray Sheet
Executive Summary
Celera Genomics' newly constructed, 33,000 square foot proteomics facility in Rockville, Maryland will be able to sequence 1 mil. proteins daily in a search for new disease diagnostic markers once it is fully operational, the firm says.
You may also be interested in...
Applied Biosystems/Amersham
Court-mediated settlement concludes patent litigation between the parties with cross-licensing agreement, co-development arrangement for joint development of DNA analysis technologies. An April 2001 summary judgement found that Applied Biosystems sequencing chemistry used with the Prism 3700 DNA analyzer system did not infringe an Amersham patent (1"The Gray Sheet" April 16, 2001, p. 17). A jury trial was set to begin to resolve other infringement claims...
Applied Biosystems/Amersham
Court-mediated settlement concludes patent litigation between the parties with cross-licensing agreement, co-development arrangement for joint development of DNA analysis technologies. An April 2001 summary judgement found that Applied Biosystems sequencing chemistry used with the Prism 3700 DNA analyzer system did not infringe an Amersham patent (1"The Gray Sheet" April 16, 2001, p. 17). A jury trial was set to begin to resolve other infringement claims...
Applied Biosystems 4700 Proteomics Analyzer To Ship By March
Applied Biosystems plans to sell its Applied Biosystems 4700 proteomics analyzer at a base price of $650,000 and will offer an additional $100,000 automation package when full-scale shipments begin in March